KLK3 and posterior cortical atrophy: Since the 1990s, with the introduction of the prostate specific antigen (PSA) test for the detection of PCa, the possibility of early diagnosis has been improved and, consequently, metastatic disease and specific mortality rates have been reduced in most Western countries [3].